news

20.01.2026

Launching an Early Adopter Program — Apply now to join us
to Shape What’s Next
 

Our Early Adopter Program offers researchers the opportunity to join us in evaluating and shaping a new, advanced immunofluorescence solution.
Selected participants receive early, complimentary access to the technology and collaborate directly with our development team. By sharing real-world data and feedback, participants help refine the solution, gain recognition for their work, and contribute to the advancement of next-generation research tools.
 

Read more here
 

06.11.2025

arcoris bio raises CHF 6.3 million seed round to advance next generation biomarker technology for digital pathology

arcoris bio, a Swiss life science research tools and in vitro diagnostics company, has secured CHF 6.3 million in an oversubscribed seed financing round to advance the development and commercialization of its breakthrough MUSE® biomarker detection platform. The round was co-led by Ventura Ace and ZEISS Ventures, with participation from Zürcher Kantonalbank (ZKB) and both existing and new private investors.

Download the full press release here